000 | 01016 a2200289 4500 | ||
---|---|---|---|
005 | 20250513063459.0 | ||
264 | 0 | _c19940602 | |
008 | 199406s 0 0 eng d | ||
022 | _a1047-2797 | ||
024 | 7 |
_a10.1016/1047-2797(93)90118-n _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHennekens, C H | |
245 | 0 | 0 |
_aAntiplatelet therapy and risk of stroke. _h[electronic resource] |
260 |
_bAnnals of epidemiology _cSep 1993 |
||
300 |
_a568-70 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAspirin _xtherapeutic use |
650 | 0 | 4 |
_aCerebrovascular Disorders _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMyocardial Infarction _xprevention & control |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aJonas, M A | |
700 | 1 | _aBuring, J E | |
773 | 0 |
_tAnnals of epidemiology _gvol. 3 _gno. 5 _gp. 568-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/1047-2797(93)90118-n _zAvailable from publisher's website |
999 |
_c8167158 _d8167158 |